The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Animal Stem Cell Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The global Animal Stem Cell Therapy market size is expected to reach US$ 482.9 million by 2029, growing at a CAGR of 12.8% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Stem Cell Therapy in various end use industries. The expanding demands from the Veterinary Hospitals and Research Organizations, are propelling Animal Stem Cell Therapy market. Dogs Stem Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Horses Stem Cell Therapy segment is estimated at % CAGR for the next seven-year period.
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Stem Cell Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Stem Cell Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Stem Cell Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Stem Cell Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Stem Cell Therapy covered in this report include Ardent Animal Health, VetStem, Medrego, Vetbiologics, Vetherapy, Celavet, Magellan Stem Cells, Animal General and Stem Care Company, etc.
The global Animal Stem Cell Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Global Animal Stem Cell Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Stem Cell Therapy market, Segment by Type:
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Global Animal Stem Cell Therapy market, by Application
Veterinary Hospitals
Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animal Stem Cell Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The global Animal Stem Cell Therapy market size is expected to reach US$ 482.9 million by 2029, growing at a CAGR of 12.8% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Stem Cell Therapy in various end use industries. The expanding demands from the Veterinary Hospitals and Research Organizations, are propelling Animal Stem Cell Therapy market. Dogs Stem Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Horses Stem Cell Therapy segment is estimated at % CAGR for the next seven-year period.
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Stem Cell Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Stem Cell Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Stem Cell Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Stem Cell Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Stem Cell Therapy covered in this report include Ardent Animal Health, VetStem, Medrego, Vetbiologics, Vetherapy, Celavet, Magellan Stem Cells, Animal General and Stem Care Company, etc.
The global Animal Stem Cell Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Global Animal Stem Cell Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Stem Cell Therapy market, Segment by Type:
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Global Animal Stem Cell Therapy market, by Application
Veterinary Hospitals
Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animal Stem Cell Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Animal Stem Cell Therapy
1.1 Animal Stem Cell Therapy Market Overview
1.1.1 Animal Stem Cell Therapy Product Scope
1.1.2 Animal Stem Cell Therapy Market Status and Outlook
1.2 Global Animal Stem Cell Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Animal Stem Cell Therapy Market Size by Region (2018-2029)
1.4 Global Animal Stem Cell Therapy Historic Market Size by Region (2018-2023)
1.5 Global Animal Stem Cell Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Animal Stem Cell Therapy Market Size (2018-2029)
1.6.1 North America Animal Stem Cell Therapy Market Size (2018-2029)
1.6.2 Europe Animal Stem Cell Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Animal Stem Cell Therapy Market Size (2018-2029)
1.6.4 Latin America Animal Stem Cell Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Animal Stem Cell Therapy Market Size (2018-2029)
2 Animal Stem Cell Therapy Market by Type
2.1 Introduction
2.1.1 Dogs Stem Cell Therapy
2.1.2 Horses Stem Cell Therapy
2.1.3 Others
2.2 Global Animal Stem Cell Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Animal Stem Cell Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Animal Stem Cell Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Animal Stem Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Animal Stem Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Animal Stem Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Animal Stem Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Animal Stem Cell Therapy Revenue Breakdown by Type (2018-2029)
3 Animal Stem Cell Therapy Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Hospitals
3.1.2 Research Organizations
3.2 Global Animal Stem Cell Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Animal Stem Cell Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Animal Stem Cell Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Animal Stem Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Animal Stem Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Animal Stem Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Animal Stem Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Animal Stem Cell Therapy Revenue Breakdown by Application (2018-2029)
4 Animal Stem Cell Therapy Competition Analysis by Players
4.1 Global Animal Stem Cell Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Stem Cell Therapy as of 2022)
4.3 Date of Key Players Enter into Animal Stem Cell Therapy Market
4.4 Global Top Players Animal Stem Cell Therapy Headquarters and Area Served
4.5 Key Players Animal Stem Cell Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Animal Stem Cell Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Ardent Animal Health
5.1.1 Ardent Animal Health Profile
5.1.2 Ardent Animal Health Main Business
5.1.3 Ardent Animal Health Animal Stem Cell Therapy Products, Services and Solutions
5.1.4 Ardent Animal Health Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Ardent Animal Health Recent Developments
5.2 VetStem
5.2.1 VetStem Profile
5.2.2 VetStem Main Business
5.2.3 VetStem Animal Stem Cell Therapy Products, Services and Solutions
5.2.4 VetStem Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 VetStem Recent Developments
5.3 Medrego
5.3.1 Medrego Profile
5.3.2 Medrego Main Business
5.3.3 Medrego Animal Stem Cell Therapy Products, Services and Solutions
5.3.4 Medrego Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Vetbiologics Recent Developments
5.4 Vetbiologics
5.4.1 Vetbiologics Profile
5.4.2 Vetbiologics Main Business
5.4.3 Vetbiologics Animal Stem Cell Therapy Products, Services and Solutions
5.4.4 Vetbiologics Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Vetbiologics Recent Developments
5.5 Vetherapy
5.5.1 Vetherapy Profile
5.5.2 Vetherapy Main Business
5.5.3 Vetherapy Animal Stem Cell Therapy Products, Services and Solutions
5.5.4 Vetherapy Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Vetherapy Recent Developments
5.6 Celavet
5.6.1 Celavet Profile
5.6.2 Celavet Main Business
5.6.3 Celavet Animal Stem Cell Therapy Products, Services and Solutions
5.6.4 Celavet Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Celavet Recent Developments
5.7 Magellan Stem Cells
5.7.1 Magellan Stem Cells Profile
5.7.2 Magellan Stem Cells Main Business
5.7.3 Magellan Stem Cells Animal Stem Cell Therapy Products, Services and Solutions
5.7.4 Magellan Stem Cells Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Magellan Stem Cells Recent Developments
5.8 Animal General
5.8.1 Animal General Profile
5.8.2 Animal General Main Business
5.8.3 Animal General Animal Stem Cell Therapy Products, Services and Solutions
5.8.4 Animal General Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Animal General Recent Developments
5.9 Stem Care Company
5.9.1 Stem Care Company Profile
5.9.2 Stem Care Company Main Business
5.9.3 Stem Care Company Animal Stem Cell Therapy Products, Services and Solutions
5.9.4 Stem Care Company Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Stem Care Company Recent Developments
5.10 Animal Cell Therapies
5.10.1 Animal Cell Therapies Profile
5.10.2 Animal Cell Therapies Main Business
5.10.3 Animal Cell Therapies Animal Stem Cell Therapy Products, Services and Solutions
5.10.4 Animal Cell Therapies Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Animal Cell Therapies Recent Developments
5.11 Cell Therapy Sciences
5.11.1 Cell Therapy Sciences Profile
5.11.2 Cell Therapy Sciences Main Business
5.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Products, Services and Solutions
5.11.4 Cell Therapy Sciences Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Cell Therapy Sciences Recent Developments
5.12 Animacel
5.12.1 Animacel Profile
5.12.2 Animacel Main Business
5.12.3 Animacel Animal Stem Cell Therapy Products, Services and Solutions
5.12.4 Animacel Animal Stem Cell Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Animacel Recent Developments
6 North America
6.1 North America Animal Stem Cell Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Animal Stem Cell Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Animal Stem Cell Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Animal Stem Cell Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Animal Stem Cell Therapy Market Dynamics
11.1 Animal Stem Cell Therapy Industry Trends
11.2 Animal Stem Cell Therapy Market Drivers
11.3 Animal Stem Cell Therapy Market Challenges
11.4 Animal Stem Cell Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
